Signifier Medical Technologies awarded HCPCS codes for eXciteOSA
Category: #health  By Pankaj Singh  Date: 2022-02-23
 | 
  • sharesocial_share_icon
  • Twitter
  • Facebook
  • LinkedIn

Signifier Medical Technologies awarded HCPCS codes for eXciteOSA

Signifier Medical Technologies LLC has reportedly announced that CMS (Centers for Medicare & Medicaid Services) has set two new Level II HCPCS (Healthcare Common Procedure Coding System) codes. These codes represent eXciteOSA, the first FDA-approved de-novo device for daytime treatment of primary snoring and mild OSA (obstructive sleep apnea).

Akhil Tripathi, Signifier’s Chief Executive Officer, stated that the company is witnessing strong demand for the eXciteOSA therapy with more than 3,000 patients treated with this therapy.

Setting codes showcases a crucial achievement for health systems, physicians, payers, DME suppliers, and patients. It will allow the company to further demonstrate the real-world advantages of enhanced outcomes, substantially enhanced quality of care, and cost savings for patients. Reimbursement will aid patients in the United States diagnosed with sleep disordered breathing with an alternative to attain a new, efficient daytime treatment.

According to Dr. Marc Benton, a sleep medicine specialist and a pulmonologist based in New Jersey, eXciteOSA is an easy-to-use, non-invasive therapy that does not need patients to wear any device while sleeping. With the establishment of reimbursements, it will be easier to access eXciteOSA for a wider and diverse patient population diagnosed with sleep apnea.

For the record, Signifier is a leading provider of sleep disordered solutions. The company is focused on the production and promotion of inventive, non-invasive solutions for patients with conditions like primary snoring and Obstructive Sleep Apnea.

The Boston-based company leads the sleep therapy sector, with an aim to develop therapies that enhance population health, generate healthcare savings, and increase the quality of patient experiences.

eXciteOSA is a transformative daytime therapy device developed for treating sleep disordered breathing. It is clinically proven to focus on a common primary cause of OSA and it enhances sleep quality, health, as well as quality of life.

Source credit:

https://www.businesswire.com/news/home/20220222005659/en/Signifier-Medical-Technologies-is-Granted-HCPCS-Codes-for-eXciteOSA-to-Help-Patients-Access-Innovative-Technology



About Author

Pankaj Singh

Email: [email protected]   linkdin twitter

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

More News By Pankaj Singh

Rona Therapeutics obtains global rights to Sanofi's siRNA platform

Rona Therapeutics obtains global rights to Sanofi's siRNA platform

By Pankaj Singh

Rona Therapeutics Inc has reportedly acquired the global exclusive rights to the siRNA platform of delivery moiety and chemical modification from Sanofi S.A., in addition to four pre-clinical contenders for unrevealed ...

Toy maker Mattel inks multi-year agreement with Elon Musk’s SpaceX

Toy maker Mattel inks multi-year agreement with Elon Musk’s SpaceX

By Pankaj Singh

California-based toy manufacturing and entertainment company, Mattel, has recently signed a multi-year agreement with Elon Musk’s private spaceflight company, SpaceX.

T...

USHV partners with Willowbrook to provide quality cardiovascular care

USHV partners with Willowbrook to provide quality cardiovascular care

By Pankaj Singh

US Heart & Vascular (USHV) is reportedly partnering with Willowbrook Cardiovascular Associates to offer quality cardiovascular care in the Houston market.

USHV has a strong ma...